US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Weight Loss Drugs

1,477.81

+24.481.68%

Number of Gainers:5

Number of Losers:2

Number of Flat:- -

PE:- -

High:1,484.41

Open:1,453.50

Low:1,453.50

Close:1,453.33

Volume:42.12M

Turnover:5.38B

Market Cap:1.54T

Float Cap:1.48T

Loading ...

Kepler Capital Keeps Their Hold Rating on Novo Nordisk (0QIU)

Eli Lilly (LLY) Is Up 6.0% After Bariatric‑Level Retatrutide Data – Has The Bull Case Changed?

Simply Wall St.

Pfizer Juggles Trial Win, Setback and New Vaccine Bet

Eli Lilly & Co Surges on Powerful Pipeline Hopes

Eli Lilly’s Engage Bio Acquisition Could Unlock A Genetic Medicine Goldmine!

Should New Phase 2 Oral VK2735 Weight-Loss Data Require Action From Viking Therapeutics (VKTX) Investors?

Simply Wall St.

Does Medicine's New Obsession Really Work? -- Barron's

Market View -- Barrons.com

Centessa Pharmaceuticals Plc - Hsr Act Expiration Satisfies One Closing Condition for Lilly-Centessa Deal - SEC Filing

THOMSON REUTERS

Novo Nordisk's High-Dose Wegovy Single-Dose Pen Receives Positive EU CHMP Opinion

Novo Nordisk Wins CHMP Backing for High-Dose Wegovy Single-Dose Pen in EU

Pfizer’s Bevacizumab Biosimilar Study in Japan: What Investors Should Watch

Amgen Expands Lung Cancer Pipeline With New Tarlatamab Combo Study

Novo Nordisk Expands Obesity Reach With AMAZE 3 Sleep Apnoea Trial

Eli Lilly Expands Heart Failure Pipeline With New Phase 1 Trial of LY3971297

Pfizer Advances New Migraine Tablet Formulation With Phase 1 Bioequivalence Study

Pfizer’s Phase 3 Lyme Vaccine Trial Nears the Finish Line: What Investors Should Know

Pfizer Terminates Early KRAS Cancer Trial: What It Means for PFE Investors

Eli Lilly’s Remternetug Study Reaches Completion, Setting the Stage in Alzheimer’s Drug Race

Novo Nordisk A/S Stock Rises Friday, Outperforms Market

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BK4599/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4599","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4599\",,,,,undefined,":{"symbol":"BK4599","market":"US","secType":"PLATE","nameCN":"Weight Loss Drugs","latestPrice":1477.8087,"timestamp":1779479999999,"preClose":1453.33,"halted":0,"volume":42124834,"delay":0,"changeRate":0.016843,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Market Closed","change":24.47876,"latestTime":"05-22 16:00:00 EDT","open":1453.5048,"high":1484.4083,"low":1453.5048,"amount":5378198279.878241,"amplitude":0.021264,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1779782400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":8.918129,"peRate":24.929282,"turnoverRate":0.003939,"increases":5,"decrements":2,"flats":0,"marketCap":1543288176448,"floatMarketCap":1484913789888},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4599\",,,,,undefined,":{"symbol":"BK4599","high":1484.4083,"amplitude":0.021264,"preClose":1453.33,"low":1453.5048,"pbRate":"8.918129","latestPrice":1477.8087,"volume":42124834,"delay":0,"open":1453.5048,"prevYearClose":1494.5856,"prevWeekClose":1411.0687,"prevMonthClose":1354.7192,"prevQuarterClose":1333.3853,"fiveDayClose":1411.0687,"twentyDayClose":1305.4105,"sixtyDayClose":1442.9512,"secType":"PLATE","market":"US","turnoverRate":0.003939,"peRate":24.929282,"marketCap":1543288176448,"floatMarketCap":1484913789888,"timestamp":1779479999999,"nameCN":"Weight Loss Drugs"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4599\",,,,undefined,":{"bkCode":"BK4599","up":5,"down":2,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4599\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2637558374","title":"Kepler Capital  Keeps Their Hold Rating on Novo Nordisk (0QIU)","url":"https://stock-news.laohu8.com/highlight/detail?id=2637558374","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637558374?lang=en_us&edition=fundamental","pubTime":"2026-05-24 09:35","pubTimestamp":1779586547,"startTime":"0","endTime":"0","summary":"In a report released on May 22, David Evans from Kepler Capital maintained a Hold rating on Novo Nordisk, with a price target of DKK290.00. The com...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/kepler-capital-keeps-their-hold-rating-on-novo-nordisk-0qiu-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/kepler-capital-keeps-their-hold-rating-on-novo-nordisk-0qiu-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","NVO","LU0154236417.USD","BK4588","NVOX","IE00BKVL7J92.USD","LU1093756168.USD","BK4007","LU1093756325.SGD","BK4532","BK4599","NVOH","IE00BZ1G4Q59.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637376852","title":"Eli Lilly (LLY) Is Up 6.0% After Bariatric‑Level Retatrutide Data – Has The Bull Case Changed?","url":"https://stock-news.laohu8.com/highlight/detail?id=2637376852","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637376852?lang=en_us&edition=fundamental","pubTime":"2026-05-24 04:20","pubTimestamp":1779567617,"startTime":"0","endTime":"0","summary":"Earlier this week, Eli Lilly reported Phase 3 TRIUMPH-1 results showing its investigational obesity drug retatrutide delivered large, durable weight loss and cardiometabolic improvements in adults with obesity or overweight and at least one weight-related condition.\nThe scale of weight reduction at higher doses, approaching outcomes typically associated with bariatric surgery, highlights how retatrutide could reshape expectations for drug-based obesity treatment if ultimately approved.\nWe'll...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/285467-main-header/1756214710679","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/285467-main-header/1756214710679"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-lly/eli-lilly/news/eli-lilly-lly-is-up-60-after-bariatriclevel-retatrutide-data","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-lly/eli-lilly/news/eli-lilly-lly-is-up-60-after-bariatriclevel-retatrutide-data","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU1720051108.HKD","LU0323591593.USD","LU1989771016.USD","LU0096364046.USD","BK4585","LU0114720955.EUR","LU2746668974.SGD","IE00B7KXQ091.USD","LU0689472784.USD","SG9999014880.SGD","LU0353189763.USD","LU1548497426.USD","BK4588","LU1983299246.USD","LU1280957306.USD","LU2236285917.USD","LU2211815571.USD","IE00BK4W5M84.HKD","LU0203201768.USD","LU0964807845.USD","SG9999015952.SGD","LU0432979614.USD","LU2237443978.SGD","IE00B4JS1V06.HKD","IE00B1XK9C88.USD","LU0320765059.SGD","IE0005OL40V9.USD","IE00BN29S564.USD","LU2168564495.EUR","SG9999017495.SGD","LU1720051017.SGD","IE00BFTCPJ56.SGD","LU0079474960.USD","LU0109394709.USD","LU1804176565.USD","LU0109391861.USD","LU0417517546.SGD","LU1366192091.USD","LU2361044949.HKD","LU1868836914.USD","LU2471134952.CNY","BK4581","LU1291159041.SGD","LU1974910355.USD","ELIS","LU0823416689.USD","IE00BFSS7M15.SGD","SG9999001176.USD","LU2271345857.HKD","LU1064131342.USD","IE00BJJMRZ35.SGD","LU2028103732.USD","LU2265009873.SGD","LU1712237335.SGD","LU0823434740.USD","LU2462157665.USD","SG9999018865.SGD","SG9999015945.SGD","LU0256863902.USD","LU2750360641.GBP","BK4007","LU1623119135.USD","LU2168564222.USD","LU2471134796.USD","IE00B2B36J28.USD","BK4533","SGXZ81514606.USD","LU0354030511.USD","LU0889565916.HKD","LU0823434583.USD","SG9999015986.USD","ELIL","LU2089283258.USD","LU2168563687.JPY","LU2602419157.SGD","LU1267930730.SGD","LU0456855351.SGD","LU0882574055.USD","LU2750360997.AUD","LU1988902786.USD","LU0133085943.USD","LU2087625088.SGD","IE00BJT1NW94.SGD","LU0256863811.USD","LU0787776722.HKD","LU2471134879.HKD","SG9999014898.SGD","LU0158827948.USD","LU2491050071.SGD","LU0106261372.USD","LU0266013472.USD","BK4516","LU0094547139.USD","LU1551013425.SGD","LU0061475181.USD","LU0238689110.USD","LU2023250330.USD","IE00B1BXHZ80.USD","IE0009355771.USD","SGXZ51526630.SGD","LU2112291526.USD","LU1023059063.AUD","LU1629891620.HKD","LU0786609619.USD","LU2491050154.USD","LU2023250504.SGD","SGXZ99366536.SGD","LU0640476718.USD","LLYX","LLY","LU2552382215.SGD","LU2168564149.EUR","IE0004445015.USD","LU1323610961.USD","LU0225283273.USD","LU2896262040.SGD","IE00B4R5TH58.HKD","BK4534","LU0320765992.SGD","LU0234572021.USD","LU2023251221.USD","SG9999014906.USD","IE00BJJMRX11.SGD","LU0943347566.SGD","SG9999015978.USD","IE0002141913.USD","SG9999018857.SGD","LU0385154629.USD","SGXZ57979304.SGD","LU2237443549.SGD","LU2468319806.SGD","LU2213496289.HKD","LU1551013342.USD","LU1232071149.USD","LU1868837136.USD","IE00BKDWB100.SGD","LU1814569148.SGD","LU0672654240.SGD","LU0158827781.USD","LU2237443465.HKD","LU2552382058.USD","IE00BJLML261.HKD","LU1145028129.USD","LU1917777945.USD","LU0466842654.USD","LU2168564065.EUR","LU0820561818.USD","LU1069344957.HKD","SG9999013999.USD","LU2756315664.SGD","IE00BWXC8680.SGD","LU2456880835.USD","IE0004445239.USD","LU0354030438.USD","LU0316494557.USD","LU1035775433.USD","LU2106854487.HKD","LU0058720904.USD","LU2417539215.USD","LU2324357040.USD","LU1868836591.USD","LU1093756325.SGD","LLYZ","IE00BKPKM429.USD","LU0683600562.USD","GB00BDT5M118.USD","IE0001KFT4U8.USD","LU2063271972.USD","LU0882574139.USD","SG9999014914.USD","IE00BK4W5L77.USD","LU2089984988.USD","LU0289739699.SGD","LU2237443895.HKD","LU2360106947.USD","LU0708995401.HKD","SGXZ31699556.SGD","LU2264538146.SGD","LU0198837287.USD","LU0353189680.USD","LU1057294990.SGD","IE00BFSS8Q28.SGD","LU0122379950.USD","LU1093756168.USD","LU2357305700.SGD","LU2471134523.USD","LU1868836757.USD","LU2108987350.USD","BK4599","LU1061106388.HKD","LU2237438978.USD","LU2746668461.USD","LU0097036916.USD","LU0820561909.HKD","LU0471298777.SGD","LU0203202063.USD","IE00BJJMRY28.SGD","LU2756315318.SGD","IE00B775H168.HKD","LU0820562030.AUD","LU2361044865.SGD","LU0471298694.HKD","SG9999001176.SGD","LU0210536198.USD","LU2552382132.HKD","LU1127390331.HKD","LU1868837300.USD","LU2237443382.USD","LU2089284900.SGD","LU2491049909.HKD","LU2361045086.USD","LU0006306889.USD","LLII","LU2111349929.HKD","LU2461242641.AUD","LU2237443622.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637320505","title":"Pfizer Juggles Trial Win, Setback and New Vaccine Bet","url":"https://stock-news.laohu8.com/highlight/detail?id=2637320505","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637320505?lang=en_us&edition=fundamental","pubTime":"2026-05-23 23:02","pubTimestamp":1779548564,"startTime":"0","endTime":"0","summary":"Pfizer ( ($PFE) ) has been popular among investors this week. Here is a recap of the key news on this stock. Pfizer is quietly reshaping its pipeli...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/weekend-updates/pfizer-juggles-trial-win-setback-and-new-vaccine-bet?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/weekend-updates/pfizer-juggles-trial-win-setback-and-new-vaccine-bet?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4592","PFE","SG9999011175.SGD","BK4550","LU0306806265.USD","SG9999013999.USD","SG9999002232.USD","BK4007","BK4588","IE00B3T34201.USD","SG9999002224.SGD","LU1066053197.SGD","LU0289739699.SGD","LU0225771236.USD","LU0321505439.SGD","IE00B19Z3B42.SGD","LU0058720904.USD","LU1894683348.USD","BK4534","LU0234572021.USD","LU0868494617.USD","SG9999003800.SGD","LU0985481810.HKD","SGXZ57979304.SGD","BK4585","LU1883839398.USD","LU1894683264.USD","LU0122379950.USD","BK4533","IE000M9KFDE8.USD","LU0456855351.SGD","IE0002270589.USD","IE00BLSP4239.USD","IE00BLSP4452.SGD","IE00B19Z3581.USD","LU0170899867.USD","LU0225284248.USD","LU0306807586.USD","LU1066051498.USD","BK4599","LU1023059063.AUD","IE00BBT3K403.USD","LU0321505868.SGD","SG9999001176.SGD","BK4568","LU1057294990.SGD","BK4581","SG9999001176.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637327924","title":"Eli Lilly & Co Surges on Powerful Pipeline Hopes","url":"https://stock-news.laohu8.com/highlight/detail?id=2637327924","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637327924?lang=en_us&edition=fundamental","pubTime":"2026-05-23 22:01","pubTimestamp":1779544919,"startTime":"0","endTime":"0","summary":"Eli Lilly & Co ( ($LLY) ) has risen by 7.78%. Read on to learn why. Eli Lilly & Co shares climbed 7.78% over the past week as investors focused","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/weekend-updates/eli-lilly-co-surges-on-powerful-pipeline-hopes?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/weekend-updates/eli-lilly-co-surges-on-powerful-pipeline-hopes?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LLYZ","LLYX","LU0354030511.USD","LU0096364046.USD","IE00B4R5TH58.HKD","LU0320765059.SGD","LU0094547139.USD","ELIS","IE00BJJMRX11.SGD","LU1127390331.HKD","LU2063271972.USD","LU0198837287.USD","LU0820561818.USD","SGXZ81514606.USD","LU1323610961.USD","LU0823416689.USD","LU1804176565.USD","LU2237438978.USD","LU2746668461.USD","LU0640476718.USD","LU0943347566.SGD","LU2456880835.USD","LU2471134879.HKD","IE00BFSS7M15.SGD","LU1983299246.USD","LU1868837136.USD","LU2087625088.SGD","BK4581","LU2471134796.USD","LU2023251221.USD","LU2361044865.SGD","SG9999001176.SGD","LU0823434583.USD","LU2462157665.USD","LU0787776722.HKD","LU0006306889.USD","IE00BJT1NW94.SGD","LU2106854487.HKD","LU1917777945.USD","LU2361045086.USD","ELIL","LU1093756325.SGD","SG9999014914.USD","LU2112291526.USD","LU2168564495.EUR","LU2237443465.HKD","IE00B4JS1V06.HKD","LU0456855351.SGD","SG9999014898.SGD","LU0289739699.SGD","BK4007","LU1720051108.HKD","LU1629891620.HKD","LU0256863902.USD","LU2552382215.SGD","LU1868836591.USD","LU2471134523.USD","LU1280957306.USD","LU2271345857.HKD","LU2491050071.SGD","LU2896262040.SGD","SGXZ51526630.SGD","BK4588","LU1023059063.AUD","BK4516","LU0889565916.HKD","LU2552382058.USD","LU2211815571.USD","LU0432979614.USD","LU0109394709.USD","LU0106261372.USD","LU2168564065.EUR","LU0203202063.USD","LU2491050154.USD","LU1551013342.USD","LU1720051017.SGD","LU2750360997.AUD","LU0058720904.USD","SG9999018865.SGD","LU0122379950.USD","LU1291159041.SGD","LU2168564149.EUR","LU0466842654.USD","LU2468319806.SGD","LU2471134952.CNY","LU2089283258.USD","LU0882574139.USD","LU2236285917.USD","LU2237443382.USD","IE00BK4W5L77.USD","LU2491049909.HKD","LU2602419157.SGD","LU0320765992.SGD","SG9999015986.USD","LLY","IE00BFSS8Q28.SGD","SG9999014880.SGD","LU2028103732.USD","IE00BKPKM429.USD","LU2023250504.SGD","LLII","SG9999017495.SGD","IE00BJJMRY28.SGD","LU0323591593.USD","LU0158827948.USD","IE00B2B36J28.USD","LU0964807845.USD","LU1868837300.USD","LU1057294990.SGD","LU1145028129.USD","LU0109391861.USD","LU0210536198.USD","LU2265009873.SGD","LU2264538146.SGD","LU2417539215.USD","LU2461242641.AUD","LU1366192091.USD","LU2360106947.USD","LU0114720955.EUR","LU0689472784.USD","IE0005OL40V9.USD","LU0353189680.USD","LU0354030438.USD","LU0097036916.USD","IE00B1BXHZ80.USD","LU0133085943.USD","LU0672654240.SGD","LU2213496289.HKD","BK4585","IE00BN29S564.USD","IE00BJJMRZ35.SGD","LU2108987350.USD","IE0004445015.USD","SG9999015952.SGD","LU0256863811.USD","LU0079474960.USD","IE0004445239.USD","LU0266013472.USD","IE0001KFT4U8.USD","IE0009355771.USD","LU2237443622.USD","LU2756315664.SGD","LU2552382132.HKD","LU1712237335.SGD","LU0683600562.USD","LU1989771016.USD","LU1814569148.SGD","LU0471298694.HKD","LU2168564222.USD","LU2111349929.HKD","LU2237443549.SGD","LU0158827781.USD","LU1267930730.SGD","LU2746668974.SGD","SG9999013999.USD","SG9999014906.USD","LU1551013425.SGD","GB00BDT5M118.USD","LU1548497426.USD","IE00BJLML261.HKD","SG9999015978.USD","IE00BK4W5M84.HKD","LU1868836914.USD","BK4534","LU0203201768.USD","BK4599","LU2361044949.HKD","LU1623119135.USD","LU0820562030.AUD","LU1061106388.HKD","LU0353189763.USD","LU0820561909.HKD","LU2750360641.GBP","LU2237443978.SGD","LU1064131342.USD","LU1069344957.HKD","LU0471298777.SGD","IE00BWXC8680.SGD","LU0708995401.HKD","LU1093756168.USD","SG9999018857.SGD","LU1988902786.USD","LU2756315318.SGD","LU2089284900.SGD","SGXZ31699556.SGD","IE0002141913.USD","LU2237443895.HKD","SGXZ57979304.SGD","LU0417517546.SGD","IE00BKDWB100.SGD","LU0234572021.USD","LU0238689110.USD","LU0225283273.USD","IE00BFTCPJ56.SGD","LU1035775433.USD","LU0316494557.USD","LU2324357040.USD","SG9999001176.USD","SGXZ99366536.SGD","IE00B1XK9C88.USD","LU0385154629.USD","LU0061475181.USD","LU0882574055.USD","LU1232071149.USD","LU2089984988.USD","LU2168563687.JPY","LU2023250330.USD","LU2357305700.SGD","IE00B7KXQ091.USD","BK4533","LU0823434740.USD","SG9999015945.SGD","IE00B775H168.HKD","LU1974910355.USD","LU1868836757.USD","LU0786609619.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637787793","title":"Eli Lilly’s Engage Bio Acquisition Could Unlock A Genetic Medicine Goldmine!","url":"https://stock-news.laohu8.com/highlight/detail?id=2637787793","media":"Smartkarma","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637787793?lang=en_us&edition=fundamental","pubTime":"2026-05-23 17:04","pubTimestamp":1779527067,"startTime":"0","endTime":"0","summary":"utm_source=tiger_community","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.smartkarma.com/home/private-investor-solutions/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1868836591.USD","LU2108987350.USD","SG9999013999.USD","LU2023250330.USD","LU2471134796.USD","LU2112291526.USD","LU2461242641.AUD","LU0353189763.USD","BK4585","LU2023250504.SGD","SG9999001176.USD","LU1917777945.USD","LU2023251221.USD","LU2237443465.HKD","LU0823416689.USD","ELIS","LU2471134952.CNY","LU0094547139.USD","LU2111349929.HKD","LU0820561909.HKD","LU2237443382.USD","IE00B1XK9C88.USD","LU2265009873.SGD","IE00BK4W5L77.USD","LU0058720904.USD","IE00BJJMRX11.SGD","IE00B7KXQ091.USD","LU0456855351.SGD","SG9999015952.SGD","IE00B1BXHZ80.USD","LU1551013342.USD","LU2456880835.USD","LLY","LU0225283273.USD","LU2213496289.HKD","LU0114720955.EUR","LU2063271972.USD","LU2361044865.SGD","LU2552382215.SGD","LU2468319806.SGD","LU0234572021.USD","LU2168564495.EUR","LU2491049909.HKD","IE0002141913.USD","IE00BJJMRZ35.SGD","IE00BJLML261.HKD","SG9999018857.SGD","LU0203201768.USD","IE00BFSS8Q28.SGD","LU2324357040.USD","IE00BFSS7M15.SGD","IE0004445015.USD","SG9999015978.USD","LU0061475181.USD","LU0323591593.USD","LU0106261372.USD","SGXZ57979304.SGD","LU1974910355.USD","SG9999014906.USD","LU1868836757.USD","BK4007","LU2491050071.SGD","LU0786609619.USD","IE00BK4W5M84.HKD","LLII","BK4534","IE0009355771.USD","LU1623119135.USD","LU1291159041.SGD","SG9999014914.USD","LU1814569148.SGD","LU2750360997.AUD","LU0266013472.USD","IE00BKDWB100.SGD","IE00BKPKM429.USD","LU0640476718.USD","LU1720051017.SGD","LU0471298694.HKD","LU1323610961.USD","SG9999014880.SGD","LU1551013425.SGD","LU2361044949.HKD","BK4581","LU2756315664.SGD","LU2236285917.USD","LU2361045086.USD","SG9999018865.SGD","LU0787776722.HKD","LU0316494557.USD","IE0005OL40V9.USD","LU0432979614.USD","GB00BDT5M118.USD","LU2237443622.USD","IE00BWXC8680.SGD","LU0133085943.USD","LU0109394709.USD","LU2089283258.USD","LU2471134879.HKD","LU2168564149.EUR","BK4588","IE00B4JS1V06.HKD","LU2357305700.SGD","LU0320765059.SGD","LU1548497426.USD","LU1035775433.USD","SGXZ81514606.USD","LU0006306889.USD","LU2746668974.SGD","LU0079474960.USD","LU2471134523.USD","LU1989771016.USD","LU0882574139.USD","LU2750360641.GBP","BK4533","LU2552382058.USD","LU0672654240.SGD","IE00B4R5TH58.HKD","LU0823434583.USD","LU1061106388.HKD","LU2462157665.USD","LU0943347566.SGD","LU0689472784.USD","LU0122379950.USD","LU2264538146.SGD","LU0708995401.HKD","LU1064131342.USD","LU0353189680.USD","LU2168564065.EUR","LU0158827781.USD","LU0471298777.SGD","LU0354030511.USD","LU2237443895.HKD","LU1069344957.HKD","LU1145028129.USD","LU0823434740.USD","IE0004445239.USD","LU1868837300.USD","LU0354030438.USD","LU0158827948.USD","LU0210536198.USD","LU1127390331.HKD","LU1232071149.USD","LU2237443978.SGD","LU2168564222.USD","LU1057294990.SGD","LU2087625088.SGD","SGXZ51526630.SGD","SG9999014898.SGD","IE00BJJMRY28.SGD","IE00B775H168.HKD","LU0820561818.USD","LU2417539215.USD","SG9999015945.SGD","LU0096364046.USD","LU1093756325.SGD","LU0882574055.USD","LU1093756168.USD","BK4599","SGXZ99366536.SGD","LU2896262040.SGD","LU0385154629.USD","LU0256863902.USD","LU2211815571.USD","LU1988902786.USD","LU2360106947.USD","LU2271345857.HKD","LU1720051108.HKD","LU2237438978.USD","LU0256863811.USD","LU2089984988.USD","LU0820562030.AUD","LU2089284900.SGD","IE00B2B36J28.USD","LU1280957306.USD","LLYX","LU2756315318.SGD","LU0238689110.USD","IE00BFTCPJ56.SGD","SG9999015986.USD","LU0203202063.USD","LU1983299246.USD","LLYZ","LU0683600562.USD","IE00BJT1NW94.SGD","SG9999017495.SGD","IE0001KFT4U8.USD","LU1868837136.USD","SG9999001176.SGD","LU0889565916.HKD","LU2168563687.JPY","LU2491050154.USD","IE00BN29S564.USD","LU1804176565.USD","LU0320765992.SGD","LU0466842654.USD","ELIL","LU0097036916.USD","LU1712237335.SGD","LU2028103732.USD","BK4516","LU0417517546.SGD","SGXZ31699556.SGD","LU1868836914.USD","LU1267930730.SGD","LU0198837287.USD","LU0289739699.SGD","LU1366192091.USD","LU1629891620.HKD","LU2237443549.SGD","LU2106854487.HKD","LU1023059063.AUD","LU2746668461.USD","LU2602419157.SGD","LU0109391861.USD","LU0964807845.USD","LU2552382132.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637321579","title":"Should New Phase 2 Oral VK2735 Weight-Loss Data Require Action From Viking Therapeutics (VKTX) Investors?","url":"https://stock-news.laohu8.com/highlight/detail?id=2637321579","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637321579?lang=en_us&edition=fundamental","pubTime":"2026-05-23 15:33","pubTimestamp":1779521590,"startTime":"0","endTime":"0","summary":"Earlier in May 2026, Viking Therapeutics presented additional Phase 2 data on its oral VK2735 obesity candidate at the European Congress on Obesity in Istanbul, highlighting statistically significant, dose-dependent weight loss of up to 12.2% over 13 weeks with mostly mild to moderate gastrointestinal side effects.\nThe new poster emphasized that higher oral VK2735 doses drove early, progressive weight loss without a plateau through Week 13, while a titration approach appeared to help manage...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-vktx/viking-therapeutics/news/should-new-phase-2-oral-vk2735-weight-loss-data-require-acti","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-vktx/viking-therapeutics/news/should-new-phase-2-oral-vk2735-weight-loss-data-require-acti","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4588","BK4211","VKTX","BK4599","BK4139","ISBC","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637889323","title":"Does Medicine's New Obsession Really Work? -- Barron's","url":"https://stock-news.laohu8.com/highlight/detail?id=2637889323","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637889323?lang=en_us&edition=fundamental","pubTime":"2026-05-23 09:30","pubTimestamp":1779499800,"startTime":"0","endTime":"0","summary":"The longevity industry is booming with high-tech tests, drugs, and medical devices. What to know for your health -- and personal finances. By Elizabeth O'Brien. Abby Miller Levy thinks a lot about what really pays off in healthcare.Co-founder of venture-capital firm Primetime Partners, she invests in start-ups involved in everything from dementia prevention to \"bioidentical pellet therapy\" for better libido. Only after crunching the numbers, interviewing experts, and analyzing all of the angles do she and her partners invest.Miller Levy also takes a data-driven approach to her own health. She has undergone advanced imaging and does regular blood tests and data analysis. Her physician knows the true biological age of her vital organs; if something turns up on a scan, they're on top of it.\"There is no value you can place on early detection of cancer, heart disease, etc.,\" says Miller Levy, 51.The umbrella term for this is longevity medicine, and it's expanding rapidly. The core pitch: mo","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BWXC8680.SGD","GRMN","LU1035775433.USD","LU1623119135.USD","LU2461242641.AUD","SGXZ57979304.SGD","LU2213496289.HKD","BK4599","LU2471134796.USD","LU2491050071.SGD","LU0882574055.USD","IE00BJLML261.HKD","SG9999018857.SGD","LU0354030438.USD","HIMS","LU0061475181.USD","LU0289739699.SGD","LU2168563687.JPY","LU0114720955.EUR","LU2023250504.SGD","LU1366192091.USD","LU0154236417.USD","LU2746668974.SGD","LLYZ","LU1280957306.USD","SG9999017495.SGD","LU1629891620.HKD","LU1232071149.USD","IE0002141913.USD","BK4196","LU2552382058.USD","LU0198837287.USD","HIYY","LU0823416689.USD","LU1988902786.USD","LU0964807845.USD","BK4583","LU0256863811.USD","LU0787776722.HKD","LU2506952097.USD","LU2756315664.SGD","IE00B7KXQ091.USD","LU2896262040.SGD","SGXZ51526630.SGD","LU0203201768.USD","LU2237443549.SGD","LU0823417653.USD","BK4533","LU1323610961.USD","BK4504","SG9999014906.USD","IE0004445239.USD","IE0004445015.USD","LU0471298777.SGD","LU2265009873.SGD","LU2264538146.SGD","LU0320765059.SGD","LU2106854487.HKD","LU2417539215.USD","IE0001KFT4U8.USD","LU0210536198.USD","BK4551","IE00B4R5TH58.HKD","LLYX","LU0079474960.USD","LU1127390331.HKD","LU0820562030.AUD","BK4567","LU2361045086.USD","BK4516","BK4534","LU2211815571.USD","LU2433249047.HKD","SG9999015945.SGD","BK4078","LU2168564222.USD","LU1868836757.USD","LU0238689110.USD","LU1720051017.SGD","LU0094547139.USD","LU1551013342.USD","LU2112291526.USD","LU2237443622.USD","LU1548497426.USD","LU1551013425.SGD","LU2023250330.USD","LU2456880835.USD","LU0943347566.SGD","LU0456855351.SGD","IE00BN29S564.USD","IE00BMPRXR70.SGD","LU1145028129.USD","IE0005OL40V9.USD","LU0133085943.USD","LU1699723380.USD","LU0889565916.HKD","LU2471134523.USD","BK4548","LU0823434583.USD","LU2237443382.USD","IE00B1BXHZ80.USD","LU0256863902.USD","LU1983299246.USD","LU0158827781.USD","DGX","LU2462157665.USD","LU2491049909.HKD","GB00BDT5M118.USD","ELIL","LU0471298694.HKD","LU0786609619.USD","LU0203202063.USD","LU0640476718.USD","LLY","LU0882574139.USD","LU0353189680.USD","LU0109394709.USD","LU0708995401.HKD","LU0820561818.USD","LU1064131342.USD","LU1974910355.USD","LU2087625088.SGD","LU2210149790.SGD","LU2361044949.HKD","LU2750360997.AUD","IE00BK4W5M84.HKD","LU2108987350.USD","IE00B1XK9C88.USD","LU2552382132.HKD","LU2746668461.USD","LU2756315318.SGD","NVO","LU2237443895.HKD","SG9999014880.SGD","LU2552382215.SGD","LU1291159041.SGD","LU1814569148.SGD","BK4007","LU1069344957.HKD","LU2063271972.USD","LU1093756325.SGD","LU2089984988.USD","LU0823434740.USD","IE00BZ1G4Q59.USD","LU1267930730.SGD","IE00BFSS8Q28.SGD","LU2602419157.SGD","BK4532","LU0354030511.USD","LU2111349929.HKD","LU0122379950.USD","LU2357305700.SGD","LU2360106947.USD","LU2095319765.USD","LU0385154629.USD","LU2237443465.HKD","IE00BK4W5L77.USD","LU0096364046.USD","IE00B4JS1V06.HKD","SGXZ31699556.SGD","LLII","IE00BJJMRX11.SGD","LU0320765992.SGD","LU0417517546.SGD","LU1571399168.USD","LU2271345857.HKD","LU0353189763.USD","LU1868836591.USD","LU1868837300.USD","SG9999001176.USD","LU2023251221.USD","LU0006306889.USD","LU0950375773.USD","LU2237438978.USD","BK4585","LU0323591593.USD","LU0689472784.USD","LU0432979614.USD","SG9999018865.SGD","LU0823417737.USD","LU0097036916.USD","LU1917777945.USD","LU1057294990.SGD","LU1061106388.HKD","HMYY","LU2491050154.USD","SGXZ81514606.USD","LU0225283273.USD","IE00B2B36J28.USD","SG9999014914.USD","LU0466842654.USD","SG9999015986.USD","LU2125909593.SGD","LU2210150020.SGD","SGXZ99366536.SGD","IE00BFTCPJ56.SGD","LU0683600562.USD","IE00B775H168.HKD","LU2089284900.SGD","NVOX","LU2361044865.SGD","IE00BMPRXN33.USD","IE0009355771.USD","LU2125909247.SGD","LU0820561909.HKD","LU1854103824.USD","IE00BKDWB100.SGD","LU2236285917.USD","DXCM","LU2468319806.SGD","BK4588","NVOH","LU1989771016.USD","SG9999013999.USD","LU1720051108.HKD","LU1712237335.SGD","LU2237443978.SGD","SG9999014898.SGD","LU0109391861.USD","LU2168564495.EUR","IE00BJT1NW94.SGD","LU1093756168.USD","LU2471134879.HKD","SG9999001176.SGD","HIMY","LU1923622614.USD","LU2028103732.USD","LU2471134952.CNY","HIMZ","BK4581","IE00BKVL7J92.USD","LU0316494557.USD","IE00BJJMRY28.SGD","LU2324357040.USD","IE00BFSS7M15.SGD","ELIS","IE00BKPKM429.USD","LU0266013472.USD","LU2506951875.HKD","LU0234572021.USD","LU0672654240.SGD","LU2506952170.USD","LU1804176565.USD","SG9999015952.SGD","LU2750360641.GBP","LU1868836914.USD","LU1023059063.AUD","LU0106261372.USD","BK4082","LU2168564065.EUR","LU2168564149.EUR","LU0058720904.USD","SG9999015978.USD","LU1868837136.USD","LU2089283258.USD","LU0158827948.USD","LU1854104046.USD","IE00BJJMRZ35.SGD","LU2506951958.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637328744","title":"Market View -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2637328744","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637328744?lang=en_us&edition=fundamental","pubTime":"2026-05-23 09:23","pubTimestamp":1779499380,"startTime":"0","endTime":"0","summary":"May 22: Even with some slight moderation in oil prices and bond yields, the market is more firmly leaning to the view that the Fed's next move is likely to be a rate hike, not a cut. The relentless rally in equities, signs of firming job growth, and surprisingly hawkish minutes from the April Federal Open Market Committee meeting all added to the mix. This presents Fed Chair Kevin Warsh with a rather inconvenient truth -- if he is still advocating for rate cuts, as in his Senate testimony last month, he may be a lonesome dove. The case for cuts simply isn't there at the moment, and there are likely precious few Fed voters who would even consider such a step at this point.plexity and capital intensity involved). At the same time, it isn't yet clear how the gains from AI might ultimately be spread across the economy, and there are likely to be periods ahead when realized profit growth is weaker. We advocate staying invested to benefit from rising earnings while diversifying across the AI","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BFXG1179.USD","LU2125154778.USD","BK4592","LU0114720955.EUR","LU0289739699.SGD","LU1571399168.USD","IE00BFTCPJ56.SGD","SG9999011175.SGD","LU1868837300.USD","LU0234572021.USD","LU2133065610.SGD","IE00B2B36J28.USD","BK4585","LU0225284248.USD","IE00B19Z3581.USD","LU1066051498.USD","BK4534","IE00B19Z3B42.SGD","LU1023059063.AUD","LU1430594728.SGD","SG9999001176.SGD","LU1868837136.USD","LU0306806265.USD","LU1718418525.SGD","LU1670711123.USD","LU1868836914.USD","LU2360032135.SGD","BK4581","LU0321505868.SGD","LU2242646821.SGD","LU2242652126.USD","LU0122379950.USD","SGXZ57979304.SGD","IE00BLSP4239.USD","LU0237698245.USD","LU1670710661.SGD","IE0009355771.USD","LU1093756168.USD","LU1670710588.SGD","LU1868836591.USD","LU1066053197.SGD","LU1868836757.USD","LU1989771016.USD","IE00BJT1NW94.SGD","IE00B3T34201.USD","IE00BJJMRZ35.SGD","LU1894683264.USD","LU0985481810.HKD","BK4599","IE0002141913.USD","LU2125154935.USD","LU1585245621.USD","BK4550","LU1093756325.SGD","IE00BBT3K403.USD","SG9999013999.USD","LU1883839398.USD","BK4559","IE000M9KFDE8.USD","PFE","BK4568","LU0225771236.USD","BK4532","LU0058720904.USD","LU0432979614.USD","SG9999003800.SGD","LU0456855351.SGD","LU1291159041.SGD","IE00BLSP4452.SGD","LU1261432733.SGD","BMY","LU0170899867.USD","LU1057294990.SGD","LU0096364046.USD","LU1983299246.USD","LU1032466523.USD","LU1074936037.SGD","SG9999001176.USD","BK4007","LU0321505439.SGD","IE0002270589.USD","SG9999002224.SGD","LU0306807586.USD","LU0868494617.USD","BK4533","LU0061475181.USD","LU0267386448.USD","SG9999002232.USD","LU1670711040.USD","LU1894683348.USD","LU0882574055.USD","IE00BSNM7G36.USD","BK4588","LU1323610961.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637342885","title":"Centessa Pharmaceuticals Plc - Hsr Act Expiration Satisfies One Closing Condition for Lilly-Centessa Deal - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2637342885","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637342885?lang=en_us&edition=fundamental","pubTime":"2026-05-23 04:56","pubTimestamp":1779483376,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260522:nFWN41Z16F:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1127390331.HKD","LU0006306889.USD","IE00B1BXHZ80.USD","LU1551013425.SGD","LU0354030438.USD","LU2213496289.HKD","LU2112291526.USD","GB00BDT5M118.USD","LU0079474960.USD","LU0210536198.USD","LU1064131342.USD","LU2237443622.USD","LU1035775433.USD","LU2108987350.USD","SG9999014880.SGD","LU1623119135.USD","LU1093756325.SGD","IE00B4JS1V06.HKD","LU2746668974.SGD","LU2361045086.USD","SG9999015952.SGD","LU2023250504.SGD","LU2168564149.EUR","LU0882574139.USD","LU2237443382.USD","LLY","SG9999014898.SGD","SG9999017495.SGD","SGXZ31699556.SGD","IE00BKPKM429.USD","LU2168564495.EUR","LU0061475181.USD","LU0456855351.SGD","LU2491049909.HKD","IE00BJJMRZ35.SGD","IE0001KFT4U8.USD","LU0256863811.USD","LU1093756168.USD","LU1366192091.USD","LU1629891620.HKD","LU2750360997.AUD","BK4535","ELIL","LU2552382215.SGD","LU2417539215.USD","LU0471298777.SGD","BK4581","LU2468319806.SGD","LU2602419157.SGD","LU0094547139.USD","LU1814569148.SGD","SG9999015986.USD","LU2264538146.SGD","IE0009355771.USD","LU2896262040.SGD","LU2756315318.SGD","LU0256863902.USD","IE00BJJMRX11.SGD","LU1917777945.USD","LU2746668461.USD","LU2756315664.SGD","BK4516","LU2357305700.SGD","LU2089284900.SGD","LU0466842654.USD","LU0158827948.USD","IE00BWXC8680.SGD","LU2237443978.SGD","LU1267930730.SGD","LU0823434740.USD","LU2236285917.USD","LU2063271972.USD","LU2461242641.AUD","BK4139","LU0320765059.SGD","LU2111349929.HKD","SG9999001176.SGD","SG9999018857.SGD","SG9999001176.USD","BK4539","BK4533","IE00B1XK9C88.USD","LU0820562030.AUD","IE00BJT1NW94.SGD","LU2265009873.SGD","LU0109391861.USD","LU0158827781.USD","LU2237443895.HKD","SG9999014914.USD","IE0002141913.USD","LU1988902786.USD","LU1712237335.SGD","LU0198837287.USD","LU1804176565.USD","LU0203202063.USD","LU0096364046.USD","LU2237438978.USD","LU0106261372.USD","CNTA","LU0708995401.HKD","LU0823434583.USD","IE00BK4W5L77.USD","LU2491050071.SGD","LU0238689110.USD","LU0354030511.USD","LU1974910355.USD","LU0320765992.SGD","LU2361044865.SGD","IE00BK4W5M84.HKD","SGXZ57979304.SGD","LU0289739699.SGD","LU1291159041.SGD","LU2271345857.HKD","LU0133085943.USD","LU0234572021.USD","IE00BFSS8Q28.SGD","LU2023251221.USD","LU0683600562.USD","LU1868837300.USD","LU2237443465.HKD","BK4585","LU2360106947.USD","LU2456880835.USD","LLII","LU0820561909.HKD","LU2750360641.GBP","LU0058720904.USD","SG9999015945.SGD","LU2361044949.HKD","LU2106854487.HKD","IE0004445239.USD","LU0943347566.SGD","LLYX","LU1983299246.USD","BK4007","LU1280957306.USD","LU0417517546.SGD","LU1069344957.HKD","SG9999015978.USD","IE00BFSS7M15.SGD","LU1720051017.SGD","LU0672654240.SGD","IE00BKDWB100.SGD","IE0004445015.USD","LU0114720955.EUR","LU0882574055.USD","LU1145028129.USD","LU2471134879.HKD","LU2471134523.USD","LU2237443549.SGD","IE00BN29S564.USD","LU0889565916.HKD","LU0353189680.USD","LU0786609619.USD","SGXZ51526630.SGD","SGXZ81514606.USD","LU1548497426.USD","LU2168564065.EUR","SG9999018865.SGD","LU0109394709.USD","LU2028103732.USD","LU2462157665.USD","LU1989771016.USD","LU2552382132.HKD","SG9999013999.USD","LU1023059063.AUD","LU1061106388.HKD","LU1868836591.USD","LU0122379950.USD","LU2168563687.JPY","LU0203201768.USD","IE00B7KXQ091.USD","LU0097036916.USD","LU1720051108.HKD","LU2471134796.USD","LU0820561818.USD","LU2324357040.USD","LU1868836757.USD","BK4599","LU2089984988.USD","LU0689472784.USD","IE00BJJMRY28.SGD","LLYZ","ELIS","LU0385154629.USD","SG9999014906.USD","BK4534","LU1057294990.SGD","LU2023250330.USD","LU2552382058.USD","LU1868837136.USD","LU0640476718.USD","LU0787776722.HKD","BK4588","LU1232071149.USD","LU0353189763.USD","IE00BFTCPJ56.SGD","IE0005OL40V9.USD","IE00BJLML261.HKD","LU0316494557.USD","LU0471298694.HKD","LU1551013342.USD","LU2211815571.USD","LU2087625088.SGD","SGXZ99366536.SGD","LU2491050154.USD","LU0432979614.USD","LU1323610961.USD","LU2168564222.USD","LU0225283273.USD","LU1868836914.USD","LU0823416689.USD","LU2089283258.USD","LU0964807845.USD","IE00B775H168.HKD","IE00B4R5TH58.HKD","LU2471134952.CNY","IE00B2B36J28.USD","LU0323591593.USD","LU0266013472.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167068536","title":"Novo Nordisk's High-Dose Wegovy Single-Dose Pen Receives Positive EU CHMP Opinion","url":"https://stock-news.laohu8.com/highlight/detail?id=1167068536","media":"Deep News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167068536?lang=en_us&edition=fundamental","pubTime":"2026-05-23 03:03","pubTimestamp":1779476638,"startTime":"0","endTime":"0","summary":"Novo Nordisk announced on May 22 that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has adopted a positive opinion, recommending the approval of the...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4007","LU0154236417.USD","LU1093756325.SGD","IE00BKVL7J92.USD","LU1093756168.USD","BK4599","NVOH","IE00BZ1G4Q59.USD","NVOX","BK4532","BK4588","NVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637349722","title":"Novo Nordisk Wins CHMP Backing for High-Dose Wegovy Single-Dose Pen in EU","url":"https://stock-news.laohu8.com/highlight/detail?id=2637349722","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637349722?lang=en_us&edition=fundamental","pubTime":"2026-05-23 02:57","pubTimestamp":1779476236,"startTime":"0","endTime":"0","summary":"The latest update is out from Novo Nordisk ( ($NVO) ). On May 22, 2026, Novo Nordisk announced that the European Medicines Agency’s Committee for M...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/novo-nordisk-wins-chmp-backing-for-high-dose-wegovy-single-dose-pen-in-eu?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/novo-nordisk-wins-chmp-backing-for-high-dose-wegovy-single-dose-pen-in-eu?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","NVOX","BK4007","BK4588","NVOH","LU1093756325.SGD","IE00BKVL7J92.USD","BK4599","LU1093756168.USD","LU0154236417.USD","BK4532","IE00BZ1G4Q59.USD","NVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637345048","title":"Pfizer’s Bevacizumab Biosimilar Study in Japan: What Investors Should Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2637345048","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637345048?lang=en_us&edition=fundamental","pubTime":"2026-05-23 00:35","pubTimestamp":1779467748,"startTime":"0","endTime":"0","summary":"Pfizer Inc ($PFE) announced an update on their ongoing clinical study. Pfizer Inc. (PFE) is running an observational study called “BEVACIZUMAB BS I...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/pfizers-bevacizumab-biosimilar-study-in-japan-what-investors-should-watch?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/pfizers-bevacizumab-biosimilar-study-in-japan-what-investors-should-watch?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0289739699.SGD","LU0122379950.USD","LU0234572021.USD","LU1883839398.USD","SG9999013999.USD","IE00B19Z3581.USD","BK4585","LU0058720904.USD","IE00B3T34201.USD","LU0868494617.USD","BK4599","LU1066051498.USD","LU0321505868.SGD","PFE","LU0225284248.USD","SG9999002232.USD","BK4550","BK4534","LU0225771236.USD","LU1057294990.SGD","BK4007","SG9999001176.SGD","SG9999001176.USD","BK4588","BK4533","SG9999011175.SGD","SG9999003800.SGD","LU1894683348.USD","LU0456855351.SGD","BK4592","SG9999002224.SGD","LU0170899867.USD","LU0306807586.USD","LU1066053197.SGD","LU0321505439.SGD","IE00BBT3K403.USD","LU1894683264.USD","IE0002270589.USD","IE00BLSP4239.USD","LU0985481810.HKD","IE00B19Z3B42.SGD","LU0306806265.USD","BK4581","IE000M9KFDE8.USD","IE00BLSP4452.SGD","BK4568","SGXZ57979304.SGD","LU1023059063.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637534504","title":"Amgen Expands Lung Cancer Pipeline With New Tarlatamab Combo Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2637534504","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637534504?lang=en_us&edition=fundamental","pubTime":"2026-05-23 00:34","pubTimestamp":1779467698,"startTime":"0","endTime":"0","summary":"Amgen Inc ($AMGN) announced an update on their ongoing clinical study. Amgen Inc. has launched a phase 1b study in small cell lung cancer that test...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/amgen-expands-lung-cancer-pipeline-with-new-tarlatamab-combo-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/amgen-expands-lung-cancer-pipeline-with-new-tarlatamab-combo-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0289739699.SGD","LU1061106388.HKD","AMGN","LU0122379950.USD","BK4585","LU2112291526.USD","LU0058720904.USD","LU0868494617.USD","BK4599","LU2089984988.USD","LU2242652126.USD","BK4534","LU1057294990.SGD","LU2242646821.SGD","LU1983299246.USD","BK4139","LU1023059063.AUD","BK4588","LU1571399168.USD","IE00BFTCPJ56.SGD","BK4533","SG9999001440.SGD","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","LU0889565916.HKD","IE0002141913.USD","IE00B4R5TH58.HKD","LU0109394709.USD","BK4566","BK4581","IE00B2B36J28.USD","LU2468319806.SGD","LU0320765992.SGD","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637345072","title":"Novo Nordisk Expands Obesity Reach With AMAZE 3 Sleep Apnoea Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2637345072","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637345072?lang=en_us&edition=fundamental","pubTime":"2026-05-23 00:34","pubTimestamp":1779467687,"startTime":"0","endTime":"0","summary":"Novo Nordisk ($NVO) announced an update on their ongoing clinical study. Novo Nordisk is running a phase 3 study called AMAZE 3 to test a new weekl...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/novo-nordisk-expands-obesity-reach-with-amaze-3-sleep-apnoea-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/novo-nordisk-expands-obesity-reach-with-amaze-3-sleep-apnoea-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4599","BK4532","BK4585","LU0154236417.USD","NVOH","LU1093756325.SGD","IE00BZ1G4Q59.USD","LU1093756168.USD","NVOX","BK4007","IE00BKVL7J92.USD","NVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637345049","title":"Eli Lilly Expands Heart Failure Pipeline With New Phase 1 Trial of LY3971297","url":"https://stock-news.laohu8.com/highlight/detail?id=2637345049","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637345049?lang=en_us&edition=fundamental","pubTime":"2026-05-23 00:34","pubTimestamp":1779467664,"startTime":"0","endTime":"0","summary":"Eli Lilly And Company ($LLY) announced an update on their ongoing clinical study. Study Overview: Eli Lilly and Company (LLY) has launched a Phase ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/eli-lilly-expands-heart-failure-pipeline-with-new-phase-1-trial-of-ly3971297?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/eli-lilly-expands-heart-failure-pipeline-with-new-phase-1-trial-of-ly3971297?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LU0672654240.SGD","LU2063271972.USD","LU1145028129.USD","IE00BWXC8680.SGD","LU0689472784.USD","LU2168564065.EUR","SG9999015945.SGD","LU0786609619.USD","LU2756315664.SGD","LU1232071149.USD","LU2089284900.SGD","LU2471134879.HKD","LU0943347566.SGD","SG9999001176.SGD","LU0823416689.USD","LU0006306889.USD","LU0114720955.EUR","LU2023250330.USD","LU0471298694.HKD","LU2471134523.USD","LU1548497426.USD","LU2750360641.GBP","LU2461242641.AUD","IE0005OL40V9.USD","LU1551013425.SGD","LU2089984988.USD","LU1868836757.USD","SG9999015986.USD","LU0466842654.USD","LU0225283273.USD","LU1720051017.SGD","LU0096364046.USD","LU2237443465.HKD","LU1712237335.SGD","LU1127390331.HKD","LU0203201768.USD","SGXZ51526630.SGD","LU1057294990.SGD","LU1093756168.USD","LU2468319806.SGD","LU0061475181.USD","LU2552382215.SGD","SGXZ99366536.SGD","BK4588","LU0158827781.USD","LU2417539215.USD","LU1064131342.USD","LU1267930730.SGD","LU2456880835.USD","IE00BJT1NW94.SGD","LLYZ","LU2089283258.USD","LU0820562030.AUD","LU0683600562.USD","LU0882574055.USD","IE00BFTCPJ56.SGD","IE00BFSS7M15.SGD","LU0079474960.USD","LU0198837287.USD","LU0964807845.USD","LU2361045086.USD","LU2491050071.SGD","LU2237443382.USD","LU0058720904.USD","LU1280957306.USD","LU1551013342.USD","LU1868836914.USD","LU0471298777.SGD","LU2746668974.SGD","LU1989771016.USD","LU0266013472.USD","LU0320765059.SGD","LU2491049909.HKD","IE0004445239.USD","LU2360106947.USD","LU2491050154.USD","IE00BJJMRX11.SGD","LU2552382058.USD","LU0097036916.USD","LU1983299246.USD","BK4599","LU2746668461.USD","IE00B1XK9C88.USD","BK4581","LU2108987350.USD","LU2552382132.HKD","LU2265009873.SGD","IE00B1BXHZ80.USD","LU2750360997.AUD","IE00B2B36J28.USD","LU1988902786.USD","SGXZ81514606.USD","LU1868836591.USD","SG9999014914.USD","LU1061106388.HKD","LU1291159041.SGD","LU0417517546.SGD","LLII","BK4516","LU0158827948.USD","LU0787776722.HKD","LLYX","LU2237443978.SGD","LU1804176565.USD","LU2112291526.USD","ELIS","LU2168564495.EUR","LU2462157665.USD","IE0002141913.USD","IE00BN29S564.USD","LU0385154629.USD","LLY","LU2602419157.SGD","IE0004445015.USD","LU0353189763.USD","IE00BK4W5L77.USD","LU2168564149.EUR","LU0210536198.USD","LU0203202063.USD","SG9999017495.SGD","LU1720051108.HKD","LU0133085943.USD","SGXZ31699556.SGD","LU1035775433.USD","ELIL","SG9999018857.SGD","SG9999014880.SGD","LU2111349929.HKD","BK4534","LU0823434740.USD","LU0889565916.HKD","LU2087625088.SGD","LU2471134796.USD","LU1093756325.SGD","LU1629891620.HKD","LU0256863902.USD","LU0820561818.USD","LU0316494557.USD","IE00BJJMRZ35.SGD","LU2168564222.USD","LU2361044949.HKD","LU0354030438.USD","LU0353189680.USD","IE00B4R5TH58.HKD","LU2264538146.SGD","LU0823434583.USD","LU0640476718.USD","LU1023059063.AUD","BK4533","LU0708995401.HKD","LU2236285917.USD","BK4007","LU0882574139.USD","LU0106261372.USD","LU1623119135.USD","LU1974910355.USD","IE00B7KXQ091.USD","LU0122379950.USD","LU2896262040.SGD","SG9999015952.SGD","LU2471134952.CNY","LU0456855351.SGD","LU0354030511.USD","LU2324357040.USD","SG9999014898.SGD","IE00BKPKM429.USD","LU0820561909.HKD","LU0432979614.USD","IE00B4JS1V06.HKD","LU1868837300.USD","LU2361044865.SGD","LU2237443549.SGD","LU0323591593.USD","IE0001KFT4U8.USD","LU2106854487.HKD","LU2271345857.HKD","LU0320765992.SGD","LU0234572021.USD","LU2237438978.USD","LU2023250504.SGD","IE00B775H168.HKD","IE0009355771.USD","IE00BK4W5M84.HKD","SG9999013999.USD","LU2168563687.JPY","SG9999001176.USD","IE00BFSS8Q28.SGD","IE00BJJMRY28.SGD","LU1323610961.USD","LU2213496289.HKD","SG9999015978.USD","LU0094547139.USD","LU1868837136.USD","SG9999014906.USD","LU0109394709.USD","LU1069344957.HKD","LU1814569148.SGD","LU0256863811.USD","LU2023251221.USD","SGXZ57979304.SGD","IE00BJLML261.HKD","LU2357305700.SGD","LU0238689110.USD","LU2237443895.HKD","LU1917777945.USD","LU2237443622.USD","LU2211815571.USD","IE00BKDWB100.SGD","SG9999018865.SGD","LU2756315318.SGD","LU0109391861.USD","LU2028103732.USD","GB00BDT5M118.USD","LU1366192091.USD","LU0289739699.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637450763","title":"Pfizer Advances New Migraine Tablet Formulation With Phase 1 Bioequivalence Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2637450763","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637450763?lang=en_us&edition=fundamental","pubTime":"2026-05-23 00:34","pubTimestamp":1779467654,"startTime":"0","endTime":"0","summary":"Pfizer Inc ($PFE) announced an update on their ongoing clinical study. Pfizer Inc. (PFE) is preparing a Phase 1 study called “A PHASE 1, OPEN LABEL...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/pfizer-advances-new-migraine-tablet-formulation-with-phase-1-bioequivalence-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/pfizer-advances-new-migraine-tablet-formulation-with-phase-1-bioequivalence-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0306807586.USD","LU0058720904.USD","IE00BLSP4452.SGD","SG9999002224.SGD","SG9999003800.SGD","LU0234572021.USD","SG9999002232.USD","IE00B19Z3581.USD","SG9999001176.SGD","BK4533","BK4534","BK4592","LU1023059063.AUD","IE00BBT3K403.USD","LU1066053197.SGD","SG9999001176.USD","LU1894683348.USD","LU0321505439.SGD","LU0225284248.USD","IE00BLSP4239.USD","IE0002270589.USD","IE00B19Z3B42.SGD","PFE","IE000M9KFDE8.USD","LU1066051498.USD","BK4581","LU1883839398.USD","LU0985481810.HKD","LU0289739699.SGD","LU1894683264.USD","BK4588","BK4599","SG9999011175.SGD","LU0868494617.USD","LU0321505868.SGD","BK4568","LU0225771236.USD","LU0170899867.USD","LU0456855351.SGD","SGXZ57979304.SGD","IE00B3T34201.USD","BK4550","BK4007","BK4585","LU1057294990.SGD","LU0122379950.USD","LU0306806265.USD","SG9999013999.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637345025","title":"Pfizer’s Phase 3 Lyme Vaccine Trial Nears the Finish Line: What Investors Should Know","url":"https://stock-news.laohu8.com/highlight/detail?id=2637345025","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637345025?lang=en_us&edition=fundamental","pubTime":"2026-05-23 00:32","pubTimestamp":1779467540,"startTime":"0","endTime":"0","summary":"Pfizer Inc ($PFE) announced an update on their ongoing clinical study. The Phase 3 trial “A Phase 3, Multicenter, Placebo-Controlled, Randomized, O...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/pfizers-phase-3-lyme-vaccine-trial-nears-the-finish-line-what-investors-should-know?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/pfizers-phase-3-lyme-vaccine-trial-nears-the-finish-line-what-investors-should-know?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1894683348.USD","PFE","BK4568","IE00B19Z3581.USD","LU1066051498.USD","LU0234572021.USD","BK4592","SG9999002232.USD","SG9999011175.SGD","SG9999001176.SGD","SG9999002224.SGD","IE0002270589.USD","LU0868494617.USD","IE00B19Z3B42.SGD","IE000M9KFDE8.USD","LU0985481810.HKD","LU1894683264.USD","SG9999013999.USD","SGXZ57979304.SGD","IE00BBT3K403.USD","LU0289739699.SGD","LU0170899867.USD","BK4534","LU0225284248.USD","LU0122379950.USD","LU0306806265.USD","LU0321505868.SGD","BK4585","LU1066053197.SGD","BK4581","LU0058720904.USD","SG9999001176.USD","BK4599","IE00BLSP4452.SGD","IE00BLSP4239.USD","BK4533","LU0306807586.USD","BK4588","LU1057294990.SGD","BK4550","IE00B3T34201.USD","LU0321505439.SGD","LU0225771236.USD","SG9999003800.SGD","LU1883839398.USD","LU1023059063.AUD","BK4007","LU0456855351.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637090345","title":"Pfizer Terminates Early KRAS Cancer Trial: What It Means for PFE Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2637090345","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637090345?lang=en_us&edition=fundamental","pubTime":"2026-05-23 00:32","pubTimestamp":1779467531,"startTime":"0","endTime":"0","summary":"Pfizer Inc ($PFE) announced an update on their ongoing clinical study. Pfizer Inc. (PFE) has ended its Phase 1 trial NCT06704724, titled “A PHASE 1...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/pfizer-terminates-early-kras-cancer-trial-what-it-means-for-pfe-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/pfizer-terminates-early-kras-cancer-trial-what-it-means-for-pfe-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0306806265.USD","BK4585","LU0868494617.USD","BK4550","LU0985481810.HKD","BK4599","SG9999001176.USD","IE00BLSP4239.USD","LU0321505868.SGD","LU0289739699.SGD","BK4581","LU1057294990.SGD","LU1066053197.SGD","LU1066051498.USD","LU0306807586.USD","IE000M9KFDE8.USD","IE00BBT3K403.USD","BK4534","BK4568","LU1894683348.USD","IE00B3T34201.USD","LU0234572021.USD","BK4592","LU0122379950.USD","LU0225771236.USD","IE00BLSP4452.SGD","LU1883839398.USD","LU1023059063.AUD","SG9999013999.USD","BK4588","SG9999003800.SGD","SG9999002232.USD","PFE","IE00B19Z3B42.SGD","LU0456855351.SGD","SG9999001176.SGD","SG9999011175.SGD","LU1894683264.USD","SGXZ57979304.SGD","LU0225284248.USD","IE0002270589.USD","LU0321505439.SGD","BK4533","LU0058720904.USD","SG9999002224.SGD","IE00B19Z3581.USD","LU0170899867.USD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637345044","title":"Eli Lilly’s Remternetug Study Reaches Completion, Setting the Stage in Alzheimer’s Drug Race","url":"https://stock-news.laohu8.com/highlight/detail?id=2637345044","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637345044?lang=en_us&edition=fundamental","pubTime":"2026-05-23 00:30","pubTimestamp":1779467449,"startTime":"0","endTime":"0","summary":"Eli Lilly And Company ($LLY) announced an update on their ongoing clinical study. The phase 3 TRAILRUNNER-ALZ 1 study, officially titled “Assessmen...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/eli-lillys-remternetug-study-reaches-completion-setting-the-stage-in-alzheimers-drug-race?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/eli-lillys-remternetug-study-reaches-completion-setting-the-stage-in-alzheimers-drug-race?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1093756168.USD","LU2360106947.USD","IE00BFSS7M15.SGD","LU2471134952.CNY","LU2023250504.SGD","BK4585","LU0106261372.USD","LU1267930730.SGD","IE00BJLML261.HKD","BK4007","LU0820561818.USD","LU2602419157.SGD","LU2552382215.SGD","LU0266013472.USD","LU2168563687.JPY","LU2168564222.USD","LU2750360997.AUD","IE0004445239.USD","LU0323591593.USD","LU2111349929.HKD","LU2023251221.USD","IE0009355771.USD","LU0234572021.USD","LU1868836591.USD","LU2023250330.USD","SG9999018857.SGD","LU0210536198.USD","LU2089283258.USD","ELIL","LU2746668974.SGD","SG9999015978.USD","IE00B2B36J28.USD","LU2106854487.HKD","SG9999014880.SGD","LU1974910355.USD","LU0882574055.USD","LU2746668461.USD","LU1023059063.AUD","GB00BDT5M118.USD","LU0385154629.USD","IE00B1XK9C88.USD","LU0787776722.HKD","LU1720051108.HKD","LU1069344957.HKD","SG9999014906.USD","LU0640476718.USD","LU0058720904.USD","LU1323610961.USD","LU0672654240.SGD","LU2361045086.USD","LU0354030438.USD","IE00BFTCPJ56.SGD","LU1291159041.SGD","SG9999015945.SGD","LU2168564065.EUR","LU1988902786.USD","SG9999017495.SGD","LU2063271972.USD","IE00BJT1NW94.SGD","LU0353189763.USD","LU2491050154.USD","IE0005OL40V9.USD","LU0109391861.USD","BK4534","LU0289739699.SGD","LU1127390331.HKD","LU0882574139.USD","LU0096364046.USD","LU2236285917.USD","LU0820561909.HKD","LU2237443978.SGD","LU2237443382.USD","LU2237438978.USD","SGXZ81514606.USD","LU2491049909.HKD","SG9999014898.SGD","SG9999015952.SGD","LU0097036916.USD","LU2168564495.EUR","SG9999001176.SGD","LU0354030511.USD","LU0256863902.USD","LU1868836914.USD","LU0225283273.USD","LU0708995401.HKD","LU2271345857.HKD","LU2896262040.SGD","LU0353189680.USD","LU1366192091.USD","SG9999001176.USD","LU1629891620.HKD","IE00BKPKM429.USD","LU0316494557.USD","LU0158827781.USD","LU1280957306.USD","LU0943347566.SGD","LU0964807845.USD","LLYZ","LU2456880835.USD","IE00BJJMRX11.SGD","LU0203202063.USD","LU2361044949.HKD","IE0002141913.USD","IE00B4JS1V06.HKD","LU2265009873.SGD","LU2756315318.SGD","BK4599","LU1804176565.USD","LU0238689110.USD","LU0079474960.USD","IE00BFSS8Q28.SGD","LU2112291526.USD","LU2468319806.SGD","LU1061106388.HKD","LU0061475181.USD","LLY","IE00BN29S564.USD","LU0683600562.USD","LU2211815571.USD","IE00B775H168.HKD","LU0320765059.SGD","LU1712237335.SGD","LU0122379950.USD","LU2087625088.SGD","IE0001KFT4U8.USD","LU2471134523.USD","SGXZ57979304.SGD","LU0114720955.EUR","LU2237443895.HKD","SG9999014914.USD","IE00BWXC8680.SGD","BK4516","LU1064131342.USD","LU0198837287.USD","LU1057294990.SGD","LU1551013425.SGD","LU0823434740.USD","LU2089984988.USD","SG9999013999.USD","IE00BJJMRZ35.SGD","IE00BJJMRY28.SGD","IE00B1BXHZ80.USD","LU2028103732.USD","LU2324357040.USD","IE00B7KXQ091.USD","LU2552382132.HKD","LU2237443549.SGD","LU2357305700.SGD","LU2552382058.USD","ELIS","LU0432979614.USD","LU0417517546.SGD","LU1623119135.USD","LU0823416689.USD","SGXZ51526630.SGD","LU0133085943.USD","LU2213496289.HKD","SG9999018865.SGD","LLYX","LU0006306889.USD","LU1145028129.USD","LU1548497426.USD","LU2237443622.USD","LU1868836757.USD","SGXZ31699556.SGD","LU0471298694.HKD","LU2108987350.USD","LU0471298777.SGD","LU0889565916.HKD","LU0823434583.USD","BK4533","LU0466842654.USD","LU2168564149.EUR","LU2750360641.GBP","IE00BKDWB100.SGD","LU1232071149.USD","LU2461242641.AUD","LU0109394709.USD","LU0158827948.USD","LU0820562030.AUD","LLII","LU2491050071.SGD","LU2462157665.USD","IE00BK4W5L77.USD","LU2471134879.HKD","LU0320765992.SGD","LU1035775433.USD","LU2237443465.HKD","LU0094547139.USD","LU1814569148.SGD","LU2417539215.USD","LU1093756325.SGD","LU0203201768.USD","IE00B4R5TH58.HKD","LU1551013342.USD","LU2471134796.USD","SG9999015986.USD","LU1983299246.USD","LU2361044865.SGD","LU1868837300.USD","LU0786609619.USD","LU2756315664.SGD","LU2264538146.SGD","BK4581","LU2089284900.SGD","BK4588","LU1720051017.SGD","LU0689472784.USD","LU1868837136.USD","LU1917777945.USD","IE00BK4W5M84.HKD","LU1989771016.USD","LU0456855351.SGD","IE0004445015.USD","SGXZ99366536.SGD","LU0256863811.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637345306","title":"Novo Nordisk A/S Stock Rises Friday, Outperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2637345306","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637345306?lang=en_us&edition=fundamental","pubTime":"2026-05-23 00:02","pubTimestamp":1779465720,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of Novo Nordisk A/S advanced 1.7% to DKK289.00 Friday on what proved to be an overall favorable trading session for the stock market, with the OMX Nordic 40 Index rising 1.3% to 2,692.15.The company closed DKK244.40 short of its 52-week high of DKK533.40, which the company achieved on June 13, 2025.Trading volume was 3,962,503, compared to the 50-day average trading volume of 6,080,004.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","NVOX","BK4007","BK4588","NVOH","LU1093756325.SGD","IE00BKVL7J92.USD","BK4599","LU1093756168.USD","LU0154236417.USD","BK4532","IE00BZ1G4Q59.USD","NVO"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":16,"pageCount":1,"totalSize":304,"code":"91000000","status":"200"}]}}